Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07687888

Pharmacy-based Provision of Pre-exposure Prophylaxis (PrEP) for Adolescent Girls and Young Women in Tanzania

Implementation study comparing standard pre-exposure prophylaxis (PrEP) services to four models of pharmacy-based PrEP access for young women aged 18-24 (YW) in Tanzania. At 9 months, all sites converge to one pharmacy-based PrEP model and are randomly allocated to one of two cost sharing models to increase the program's potential for sustainability.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Age range

18 year–24 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

About this study

This study will evaluate the effectiveness of pharmacy-based PrEP implementation for YW in the Lake Zone, Tanzania. Four models for pharmacy-based PrEP delivery will be evaluated and compared to pharmacies that do not provide any PrEP services for 9 months (phase I of the implementation study). The PrEP implementation models build on one another with each pharmacy-based PrEP model providing progressively expanded access to PrEP in pharmacies for YW.

All PrEP implementation models will be implemented alongside a girl-friendly loyalty program (Mwotaji Program) offering free sexual and reproductive health products including HIV self-test kits, pregnancy tests, and contraceptives.

Comparison: Standard facility based PrEP services to YW.

After 9 months (phase II), all pharmacies will implement the best performing PrEP model, based on findings from phase I. Moreover, all 50 pharmacies will implement cost-sharing. The investigators will assess acceptability, feasibility, and potential for sustainability of the pharmacy-based PrEP models. Two cost-sharing approaches will be randomized across the CRPS in a 3:2 ratio:

  • Fee-for-service model: PrEP refills provided for 500 Tanzanian Shillings (TZS) each, a standard cash-based transaction for user fees, benchmarked with data from prior studies.
  • Loyalty hybrid model: PrEP refills provided for free with any shop purchase or a fee of 500 TZS without a purchase.

The implementation study comprises a cohort study (parent study) conducted among YW and three sub-studies:

  • Household survey (cross-sectional survey conducted with YW)
  • Pharmacy surveys (surveys conducted with pharmacy staff)
  • Stakeholder surveys (surveys conducted with health facility staff and governmental stakeholders)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(Parent study: YW cohort study):

  • Female sex;
  • Age 18-24 at the baseline visit;
  • Living in one of five study sites in Shinyanga, Geita or Kagera regions of Tanzania with no known plans to move;
  • Interested in starting PrEP;
  • Access to a mobile phone (either own phone or borrowed phone); and
  • Eligible for PrEP based on Tanzania National PrEP Guidelines behavioral screening criteria

Exclusion criteria

Currently taking PrEP (refilled a PrEP prescription within the past 28 days at enrollment).

Inclusion criteria

(Sub-study: YW household survey):

  • Female sex;
  • Age 18-24; and
  • Living in one of five study sites in Shinyanga, Geita or Kagera regions of Tanzania.

Exclusion criteria

(Sub-study: YW household survey): N/A

Inclusion criteria

(Study pharmacies):

  • Geographically located within one of five study sites in Shinyanga, Geita or Kagera regions of Tanzania;
  • Located within 4 km of at least 1 health facility that provides PrEP services and whose lab conducts creatinine and hepatitis B testing;
  • Has no planned extended closures over the next 24 months.

Exclusion criteria

(Study pharmacies): N/A

Inclusion criteria

(Sub-study: Pharmacy staff):

  • Pharmacy owners and staff affiliated with study pharmacies; and
  • ≥18 years of age.

Exclusion criteria

(Sub-study: Pharmacy staff): N/A

Inclusion criteria

(Sub-study: Stakeholders):

  • Staff employed at referral health facilities within one of five study sites in Shinyanga, Geita or Kagera regions of Tanzania or local, regional, or national government officials;
  • ≥18 years of age.

Exclusion criteria

(Sub-study: Stakeholders): N/A

Treatment and study plan

Pharmacy-based PrEP services

Behavioral

Provision of PrEP services to AGYW in pharmacies.

Distribution of HIV self-test kits

Behavioral

Provision of free HIV self-test kits to AGYW in pharmacies.

Primary outcomes

  1. Effective use of PrEP

    Time frame: 9 months

    YW received a PrEP refill for all months during which an YW reports being at risk for HIV and PrEP eligible over the 9-month study period (among PrEP initiates only)

  2. Persistent use of PrEP

    Time frame: 9 months

    YW picked up all scheduled PrEP refills without a delay of >28 days over the 9- month study period (among PrEP initiates only)

  3. Reach of PrEP implementation model

    Time frame: 9 months

    Heard of pharmacy-based PrEP services (including screening, referrals, refills, or initiation)

Secondary outcomes

  1. Acceptability of PrEP implementation model

    Time frame: 9 months, 15 months

    YW agrees that PrEP implementation model is acceptable (e.g., satisfactory, high-quality, youth-friendly, discreet, affordable); Pharmacy staff agree that PrEP implementation model is acceptable and/or consistent with AGYW needs

  2. Fidelity to PrEP implementation model

    Time frame: 9 months, 15 months

    Pharmacy provision of PrEP services (screen, provide referral, refill, or initiate AGYW on PrEP) at least once per month

  3. Feasibility of PrEP implementation model

    Time frame: 9 months, 15 months

    Agrees that PrEP implementation model at pharmacies is more accessible than seeking PrEP services at health facilities; Agrees that there is sufficient capacity (e.g., space, time, privacy, will) to deliver a particular PrEP implementation model

  4. Adoption of PrEP implementation model

    Time frame: 9 months, 15 months

    Pharmacy is implementing the PrEP model as assigned.

Study contacts

Contact information is provided by the study sponsor or research team.

Lila A Sheira, PhD MPH

CONTACT

[email protected]

Mackfallen G Anasel, PhD

CONTACT

[email protected]

+255784705072

Sponsors and collaborators

Lead sponsor

Mzumbe University - Centre of Excellence in Health Monitoring and Evaluation

Other

Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • University of California, Berkeley
  • University of California, San Francisco

Registry information

Official study title

MWOTAJI: Making Women's Options for HIV Prevention In Tanzania Accessible, and Joining in Implementation Science Capacity Building

Acronym: MWOTAJI

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Jul 7, 2026
Registry last updated
Jul 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.